Press Releases
numares completes another financing round
(No. 170) numares AG, a system provider of innovative in-vitro diagnostic systems based at BioPark Regensburg has successfully completed another financing round. The investors include Wachstumsfonds Bayern, a Bavarian growth fund managed by Bayern Kapital that will provide €2 million. The additional funds will be used to expand the development pipeline and fuel the company's continued international expansion.
read onState-of-the-Art Oncology for East Bavaria
(No. 169) The University Clinic in Regensburg and the Caritas Hospital St. Josef in Regensburg have brought the "Comprehensive Cancer Center Ostbayern" (CCCO) to life. The CCCO contributes to establising the highest medical standards for oncology and developing new diagnostic and treatment processes.
read onGrowth Capital for Lophius Biosciences
(No. 169) The Biotech company Lophius Biosciences located in BioPark Regensburg has been able to successfully conclude a further round of financing for over 4.25 million €. With this fresh capital the focused development of a new diagnostic test to detect active tuberculosis will be financed.
read onBioPark promotes e-mobility for leaseholders & visitors
BioPark Guest in the US Partner City Tempe
(No. 167) A delegation from Regensburg at the invitation of the partner city Tempe in the US Federal State of Arizona visited the biotechnology cluster there. At the moment the city is developing a similar BioPark project to Regensburg.
read onPage 24 of 69
ARCHIVE